Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Today, Fund A could not fully blame rates, because time has exposed a few mistakes — and one of them was a doozy (though understandable). That big error...
— John Hempton
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Novo Nordisk A/S
More institutional theses from Bronte Capital Amalthea Fund
The stock that amazes us is Berkshire Hathaway - currently showing (small) negative beta to the S&P 500. This is surprising...
Current valuation - 5.7x earnings, 0.5x tangible book, probably 3.5-4x normalised earnings. Ie this is...
Coca-Cola is presented as an exceptional business with high returns on capital and a powerful brand that satisfies consumer desires. While it serves...